Navigation Links
Jonathan P. Freve, CPA, Joins Spring Bank Pharmaceuticals as Vice President of Finance

MILFORD, Mass., Feb. 26, 2015 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of virus infections, today announced that Jonathan P. Freve, CPA, has been appointed Vice President of Finance, a newly created role.  Mr. Freve will be responsible for financial and administrative activities, including financial planning and reporting, accounting and risk management. He reports to Douglas J. Jensen, President and CEO.

Mr. Freve joins the Company with more than 16 years of progressive experience in the life science and technology industries ranging from venture-backed start-ups to publicly traded companies. Prior to joining Spring Bank Pharmaceuticals, he served as the Senior Director of Finance of Santaris Pharma A/S, which was acquired by F. Hoffmann-La Roche Ltd.  Previously, Mr. Freve held controller positions at  two international public companies.  Mr. Freve began his career at the Financial Accounting Standards Board (FASB) and PricewaterhouseCoopers, where he worked in the audit and transaction services practices.  Over his career, Mr. Freve has supported and worked on numerous successful initial public offerings, secondary offerings, mergers and acquisitions, ERP implementations and a variety of complex accounting matters.  Mr. Freve is a certified public accountant in Massachusetts and holds a Bachelor's degree in Business Administration from the University of Massachusetts Amherst.

Douglas J. Jensen, President and CEO, stated, "I am very pleased to welcome Jon Freve to Spring Bank Pharmaceuticals.  Jon is an accomplished financial professional with a proven track record of success and excellent leadership skills. With his strong background in accounting and finance for life sciences and technology companies, I'm very confident that Jon will make many valuable contributions to Spring Bank's continued progress."  

 "I am excited about the unique opportunity to work for Spring Bank Pharmaceuticals, an emerging biotechnology company that I believe has tremendous potential," said Mr. Freve. "I look forward to working with Doug and the team and leading the finance and accounting functions during this period of growth."

About Spring Bank Pharmaceuticals

Spring Bank Pharmaceuticals is a clinical stage biopharmaceutical company. Based on its proprietary SMNH chemistry platform, Spring Bank is developing a pipeline of products representing a new class of pharmaceuticals with a wide range of applications. These rationally designed molecules combine the selectivity of naturally occurring nucleotides with the drug- like properties of classical pharmaceuticals. The SMNHs have the properties of oral delivery, good pharmacokinetic profile, low side effects and ease of manufacture. The Company's most advanced clinical candidate, SB 9200, is a potential breakthrough drug for the treatment for HBV and other viral diseases. SB 9200 has a novel mechanism of action that involves modulation of the host immune response in the presence of viral infection.

Douglas J. Jensen
President and Chief Executive Officer
(508) 473-5993 x105


SOURCE Spring Bank Pharmaceuticals, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Hubble Telemedical Welcomes Healthcare Visionary Jonathan Lord, M.D. to Its Board of Directors
2. Aptuit Names Jonathan Goldman As CEO
3. Chief Financial Officer Jonathan M. Peacock to Leave Amgen; Company Appoints Michael A. Kelly Acting Chief Financial Officer
4. Former NBA star Jonathan Bender joins ISGP, a green technology company
5. AMC Health Names Innovative Physician Leader Jonathan Leviss Medical Director
6. Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures
7. Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers
8. Specialty Operations Solutions joins The WorkingBuildings Companies
9. Dr. M. Fatih Yanik joins Intellimedix
10. Romanoff Joins Innovative Statewide Program to Combat Abuse of Prescription Pain Medications
11. Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign
Post Your Comments:
(Date:8/26/2020)... ... , ... AseptiScope, a privately funded San Diego, California based, clinical innovation company, ... , “AseptiScope is pleased to receive this recognition,” said Kelly Powers, AseptiScope ... their hands, goggles on their eyes, covers on their shoes, and gowns on their ...
(Date:8/26/2020)... ... 2020 , ... As the U.S. struggles in its 6th month of fighting ... Wear a mask, keep your distance, wash your hands. Prevention is the best tool ... in 1977, “How much better it is to prevent disease than to cure it.” ...
(Date:8/26/2020)... , ... August 26, 2020 , ... ... the appointment of Claude E. Hooton as President and Chief Executive Officer effective ... Executive Chairman of the company’s Board of Managers. , Mr. Hooton, a ...
Breaking Medicine Technology:
(Date:9/3/2020)... ... September 03, 2020 , ... ... will be held Wednesday, April 7, to Saturday, April 10, 2021, at Wynn ... Spa Show is a national trade show for non-invasive medical aesthetic practices that ...
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... ... it has completed $3 million convertible note financing, which will be used to ... With the funds from this financing, the company will continue to expand its ...
(Date:8/31/2020)... ... August 31, 2020 , ... The ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... 10th Anniversary of Blood Cancer Awareness Month (BCAM) and its international Light ...
(Date:8/31/2020)... AURORA, Colo. (PRWEB) , ... August 31, 2020 ... ... premier provider of innovative higher-learning opportunities through high-quality, career-relevant, and affordable online education ... Emergency Responder Psychology . , Among the first of its kind in ...
(Date:8/31/2020)... Calif. (PRWEB) , ... August 31, 2020 , ... ... leadership experience working, both directly with persons with autism and other developmental disabilities, ... expertise includes early intervention, parent education, adolescents with autism, school consultation, and staff ...
Breaking Medicine News(10 mins):